Tate & Lyle Plc · LSE:TATE

Tate & Lyle — H1 FY2014 Earnings Presentation

44 slides from Tate & Lyle's earnings presentation, Nov 7, 2013

  1. Slide 1: Results for six months ended 30 September 2013

    Results for six months ended 30 September 2013 7 November 2013, London

  2. Slide 2: Agenda

    Agenda Headline Results and KPIs Javed Ahmed Financial Review Tim Lodge Operating Highlights and Progress Update Javed Ahmed Outlook Javed Ahmed 2

  3. Slide 3: Headline Results

    Headline Results Six months ended 30 September Continuing operations¹ Change 2013 20125 Change (constant (£1=US$1.54) (£1=US$1.58) currency) Adjusted operating profit2 £187m £194m - 4% - 6% - SFI up 1% in constant currency - BI down 11% in constant currency Adjusted profit before tax3 £173m £178m -

  4. Slide 4: Key Performance Indicators

    Key Performance Indicators Six months ended 30 September KPI Measure 2013 20124,5 Change6 Growth in Speciality Sales £519m £471m + 7% Food Ingredients Financial performance1 Profitability Adjusted operating profit £187m £194m - 6% Working capital Lengthened by Cash conversion cycle2 43 days 42 days

  5. Slide 5: Financial Review

    Financial Review Tim Lodge, Chief Financial Officer

  6. Slide 6: Income Statement

    Income Statement Six months ended 30 September Continuing operations1 5 2013 2012 At constant £m, unless stated (£1=US$1.54) (£1=US$1.58) currency Sales 1,737 1,631 3% 2 Adjusted operating profit - SFI 112 108 1% - BI 92 101 (11%) - Central (17) (15) (9%) 187 194 (6%) 3 Net finance expense (14) (16)

  7. Slide 7: Speciality Food Ingredients

    Speciality Food Ingredients Six months ended 30 September At £m, unless stated 2013 2012 Reported constant currency Impact of Sales 519 471 10% 7% exchange: Sales 1 £15m higher, Adjusted operating profit 112 108 3% 1% Operating profit Margin1 21.5% 22.9% £3m higher  Sales2 up by 7% with operating p

  8. Slide 8: Bulk Ingredients

    Responsibilities: Bulk Ingredients PP data : EW P&L data : VD Six months ended 30 September At £m, unless stated 2013 2012 Reported constant currency Impact of Sales 1,218 1,160 5% 2% exchange: Sales 1 £36m higher, Adjusted operating profit 92 101 (9%) (11%) Operating profit Margin1 7.5% 8.7% £3m hi

  9. Slide 9: Corn and co-products

    Corn and co-products Co-product sales1 increased by 5% to £281 million US and European Corn – spot prices 1000 300  Significant fall in US and European corn 800 250 EU corn €/mt US corn c/bu 200 prices on expectation of bumper harvests 600 150 400 100 200 50 US corn (c/bu) EU corn (€/mt)  Producti

  10. Slide 10: Interest and Tax – Continuing Operations

    Interest and Tax – Continuing Operations1 Six months ended 30 September Interest At £m, unless stated 2013 2012 constant currency 2 Net finance expense (14) (16) 14%  Lower interest charge as a Add back result of repayment of £100 - Net hedge unwind - (1) million bond Underlying net interest (14) (

  11. Slide 11: Business Transformation

    Responsibilities: Business Transformation EW check with JW Six months ended 30 September Total cumulative £m Six months to costs to Sept 2013 Sept 2013 IS/IT & Global Shared Services 20 98 Total 20 98 P&L exceptional 6 39 Capital 14 59 Total 20 98 11

  12. Slide 12: Balance Sheet

    Balance Sheet £m, unless stated 30 Sept 2013 31 Mar 2013 30 Sept 2012 Goodwill, intangibles and fixed assets 1,273 1,320 1,231 Working capital 385 532 382 Pension deficit (232) (265) (217) Other provisions (32) (35) (25) Other 28 27 25 Assets and liabilities held for sale - 1 3 Net operating assets

  13. Slide 13: Free Cash Flow

    Free Cash Flow Six months ended 30 September 2013 Continuing operations1 £m 114 5 EBITDA £239m 23 52 64 14 6 12 329 239 187 Adjusted Dep'n / Exceptionals Working Pensions Share-based Operating Capex & Net Tax Free cash 2 operating amort capital payments cash flow intangibles interest Paid flow profi

  14. Slide 14: Movements in Net Debt

    Responsibilities: Movements in Net Debt AN Six months ended 30 September £m (16) (7) (88) (10) 25 (479) 239 (336) Net debt March Free cash flow Dividends Discont’d, Net share Other Exchange Net debt 2013 Acquisitions & purchases Sept 2013 Disposals 14

  15. Slide 15: Capital allocation priorities

    Capital allocation priorities Maintain investment grade credit rating Invest in the  Provide a buffer against working capital volatility business  Invest to drive organic growth Progressive  Recognise importance of dividend to shareholders dividend policy  Grow dividend over time taking into acc

  16. Slide 16: Operating Highlights

    Operating Highlights Javed Ahmed, Chief Executive

  17. Slide 17: Speciality Food Ingredients Highlights

    Speciality Food Ingredients Highlights Speciality Food Ingredients Sales £519m  Volumes up 5% with sales1 growth of 7% at £519 million  Strong growth in Europe, Asia and Latin America Food systems (19%)  Slightly lower volumes in the US 99  Adjusted operating profit1 1% higher at £112 million 10

  18. Slide 18: Starch-based speciality ingredients

    Starch-based speciality ingredients Sales1 up 13% to £314 million with volume growth of 6%  Speciality food starches  Volume growth across all regions with strong growth in Europe, Asia and Latin America  Emerging market growth reflects strong underlying consumer demand for convenience  Speciali

  19. Slide 19: High-intensity sweeteners

    High-intensity sweeteners Sales1 up 1% at £106 million with volume growth of 6%  Good long-term growth potential for high-intensity sweeteners  Strong focus on calorie-reduction globally  Tate & Lyle well placed to address this trend  SPLENDA® Sucralose  Volumes held back by soft US beverage co

  20. Slide 20: Food systems

    Food systems Sales1 down 3% to £99 million with volumes down 8%  Focus on higher margin blends led to lower volumes  Profit ahead due to improved mix and effective control of input costs  Good level of customer interaction through new facility in Roggenhorst, Germany  New Tate & Lyle Howbetter v

  21. Slide 21: Bulk Ingredients Highlights

    Bulk Ingredients Highlights Bulk Ingredients Sales £1,218m  Sales1 up 2% to £1,218 million on flat volumes  Adjusted operating profit1 down 11% to £92 Sweeteners Co-products million 281 (50%) (23%)  Lower US sweetener volumes as a result of reduced 604 demand for soft beverages 333 Industrial  S

  22. Slide 22: Sweeteners

    Sweeteners Sales1 down 1% to £604 million with volumes 4% lower US Carbonated Soft Drinks Volume2 2013 vs 2012 (%)  US sweeteners – sales1 2% lower at £518 million 13 weeks to 13 weeks to 13 weeks to March June September  Lower HFCS volumes reflects lower carbonated soft 0% drink consumption -1% -

  23. Slide 23: Industrial starches, acidulants and ethanol

    Industrial starches, acidulants and ethanol Sales1 up 5% at £333 million with volumes up 4%  Industrial starches  Higher margins in US driven by firmer pricing  Margins in Europe squeezed by lower prices  Ethanol  Overall improvement in market conditions  Margins ahead of comparative period 

  24. Slide 24: Delivering our strategy

    Delivering our strategy Javed Ahmed, Chief Executive

  25. Slide 25: Recap: Growth in Speciality Food Ingredients from three main sources

    Recap: Growth in Speciality Food Ingredients from three main sources Grow Speciality Food Ingredients  Deeper understanding and analysis Customer  Closer interaction and collaboration  Right organisation, skills and processes Innovation  Focus resources/expertise behind key platforms  Build inf

  26. Slide 26: Focus on the Customer

    Focus on the Customer Customer visits to Global Commercial Customer visits to six main and Food Innovation Center in Chicago1 facilities globally by region2 19% Asia and Latin 41% America Europe 40% US 38% Frequency and quality of Interaction is collaboration is increasing becoming more global 1 Six

  27. Slide 27: Significant change in customer perception

    Significant change in customer perception Impact of visiting Commercial and Food Innovation Centre in Chicago on customer satisfaction1 Exceeds expectations As expected Almost as expected  Independent survey1 of 197 Speciality Food Ingredients customers in North America 100% 8% 10% 90% 80% 29%  As

  28. Slide 28: Focus on Innovation

    Focus on Innovation  New product development pipeline % split of projects by platform1 − Innovation pipeline remains healthy − Average size of each project higher today than year ago 26% Sweeteners  Recent launches and portfolio expansion 28% − PULPIZ™ Pulp Extender Health & − PromOat® Beta Glucan

  29. Slide 29: Focus on new markets

    Focus on new markets  Continued strong growth in Asia and Latin America − Strong volume growth in H1 − Increasing our coverage and direct relationships with customers  Expanding local presence and infrastructure − New Applications and technical service facilities are helping to strengthen customer

  30. Slide 30: Delivering on our strategy for Bulk Ingredients

    Delivering on our strategy for Bulk Ingredients  Bulk Ingredients’ strategy is to provide stable, long-term cash flow to fund growth in Speciality Food Ingredients  Bulk Ingredients has delivered a steady performance over the last few years through:  A relentless focus on efficiency and cost redu

  31. Slide 31: Steady progress delivering on our long-term strategy

    Steady progress delivering on our long-term strategy  Good sales growth in Speciality Food Ingredients  Strong, double digit volume growth in emerging markets  Innovation pipeline remains healthy  Continued momentum in customer collaboration  Strong balance sheet provides strategic flexibility

  32. Slide 32: Outlook for year ending 31 March 2014

    Outlook for year ending 31 March 2014 Speciality Food Ingredients  We expect to deliver growth in volumes, sales and profits across all regions for the full year Bulk Ingredients  In North America we expect solid demand for liquid sweeteners and stable demand for our other products  In Europe, lo

  33. Slide 33: Q&A

    TATE LYLE Q&A

  34. Slide 34: Supporting information

    Supporting information

  35. Slide 35: Key Financial Indicators

    Key Financial Indicators Six months ended 30 September 5 £m, unless stated 2013 2012 1,2 Profit before tax 173 178 1,2 Effective tax rate - continuing operations 18.7% 18.9% Diluted EPS - continuing operations1,2 29.9p 30.5p 2 Operating cash flow - continuing operations 329 228 Net debt 336 386 Net

  36. Slide 36: Exceptional Items

    Responsibilities: Exceptional Items MP Six months ended 30 September £m, unless stated 2013 2012 Exceptional Items Continuing operations Business transformation costs (6) (10) Gain on disposal - Columbian acidulants joint venture - 8 Exceptional costs from continuing operations (6) (2) Discontinued

  37. Slide 37: Change in Working Capital

    Responsibilities: Change in Working Capital AN Six months ended 30 September Continuing operations1 £m, unless stated 2013 2012 Decrease in inventories 151 10 Decrease/(increase) in receivables 32 (48) (Increase)/decrease in US margin calls (3) 22 (Decrease)/increase in payables (46) 20 Movement in

  38. Slide 38: Income Statement

    Responsibilities: Income Statement P&L data : VD Six months ended 30 September 4 2013 2012 £m, unless stated Cont'd Discont'd Total Cont'd Discont'd Total Sales 1,737 - 1,737 1,631 10 1,641 1 Operating profit 187 - 187 194 3 197 Net finance costs2 (14) - (14) (16) - (16) 3 Profit before tax 173 - 17

  39. Slide 39: Profit before tax

    Responsibilities: Profit before tax VD? Six months ended 30 September 2013 Continuing operations1 5 £m, unless stated 2012 Forex Activity 2013 - SFI 108 3 1 112 - BI 101 3 (12) 92 - Central (15) - (2) (17) Adjusted operating profit2 194 6 (13) 187 Net finance expense3 (16) (1) 3 (14) 4 Adjusted prof

  40. Slide 40: Reconciliation of adjusted information

    Reconciliation of adjusted information Continuing operations1 3 Six months to 30 Sept 2013 Six months to 30 Sept 2012 Adjusting Adjusting £m Reported Adjusted2 Reported Adjusted2 items items Sales 1,737 - 1,737 1,631 - 1,631 Operating profit 176 11 187 186 8 194 Net finance expense (18) 4 (14) (18)

  41. Slide 41: Exchange rates

    Exchange rates 30 Sept 31 Mar 30 Sept £m 2013 2013 2012 Closing rates US$ 1.62 1.52 1.61 Euro 1.19 1.18 1.25 used to translate Balance Sheet Average rates US$ 1.54 1.57 1.58 Euro 1.18 1.24 1.25 used to translate Income Statement 41

  42. Slide 42: Exchange Sensitivity

    Exchange Sensitivity Estimated annual movement caused by a one cent movement in the US$/€ on the translation of continuing operations’ profits £m impact on PBITEA US$ EUR Speciality Food Ingredients 1.0 0.1 Bulk Ingredients 0.7 - Central 0.1 - Impact on operating profit before interest & tax1 1.8 0.

  43. Slide 43: Debt Maturity Profile

    Responsibilities: Debt Maturity Profile MD September 2013 Undrawn committed bank £m 2013 2012 facilities £m Drawn committed bank 700 facilities Average net debt in period 439 421 600 Bonds and other Effective interest rate on gross debt 3.9% 4.1% 500 400 At period end 300 Average maturity of total g

  44. Slide 44: IAS19

    Responsibilities: IAS19 MD £m, unless stated Deduct IAS19 cost pension incl. in H1 FY13 interest reported H1 FY13 reported credit results restated Operating profit 187 - (1) 186 Net finance expense (15) (1) (2) (18) Profit before tax 172 (1) (3) 168  The change to IAS 19 modifies the basis on which

Tate & Lyle — H1 FY2014 Earnings Presentation on 6ix